Zillow’s been in the house-flipping business since 2019. After buying 3,805 homes in Q2 of this year, they are pumping the brakes. Why? They are struggling with labor, materials, and a competitive real estate market. | learn more
An interview with Toucan founder Taylor Nieman. “Toucan launched a year ago on Product Hunt, in September 2020, and it was very well received. They were the #1 product on the day.” | learn more
This is a wonderful example of “do things, tell people.” Brian Barnes, CEO of Chicago-based M1 Finance, bought a bank and wrote about it. Of interest, it seems he bought the bank personally because, M1 “has work to do before […]
Tom Tunguz muses about the parallels between public and private markets, and whether passive investing will take permanent hold in the venture capital market. There’s some basis for it, as it’s not like Series F/G/H investors are very involved in […]
“Joe Liemandt is the billionaire founder and CEO of Trilogy Software and ESW Capital (short for enterprise software) a holding company that buys software companies. It is essentially Liemandt’s family office funded by his $3 billion fortune. ESW buys US […]
“Twist is a DNA factory. They start with inputs – the A, C, T and G chemical letters that make up the base-4 code for life on earth. And they produce outputs – sequences of DNA, called oligonucleotides, whose code […]
OpenView Venture Partners does a nice job of content marketing. In this piece they interviewed 4 VCs (including two of their own partners) to create a useful list for founders to learn from. | learn more
“In 2013, I co-founded Heap, a product analytics company that I helped grow to over 200 people and $X0,000,000 in ARR before I left in 2020. In 2021, I co-founded Airplane, a developer platform for quickly creating internal tools. Here’s […]
“Not counting Excel users, there are only about 30 million programmers. Estimates put the number of Excel users between 500m and over 1 billion! It is therefore, by far, the most used programming language on the planet. It is easily […]
Elad Gil defends Silicon Valley tech startups, making the case that Theranos is not representative of them. “Theranos raised no real mainstream venture capital. None of the mainstream tech or biotech funders invested in Theranos.” | learn more